Table 1 Characteristics of the 90 patients enrolled at diagnosis.

From: Evaluation of the capability and reproducibility of RECIST 1.1. measurements by technologists in breast cancer follow-up: a pilot study

 

n = 90

Age, mean (± sd)

58 (± 12.8)

(min;max)

(24;86)

Gender, n (%)

 Male

2 (2%)

 Female

88 (98%)

Histologic finding, n (%)

 Infiltrating ductal carcinoma (IDC)

81 (90%)

 Invasive Lobular Carcinoma (ILC)

3 (3%)

 Unknow

6 (7%)

Tumor classification, n (%)

 T1

4 (4%)

 T2

17 (19%)

 T3

8 (9%)

 T4

23 (26%)

 Unknow

38 (42%)

Node involvement

 N0

19 (21%)

 N1

24 (27%)

 N2

3 (3%)

 N3

6 (7%)

 Unknow

38 (42%)

Metastases involvement

 M0

39 (43%)

 M1

26 (29%)

 Unknow

25 (28%)

TNM stage, n (%)

 Stage I

2 (2%)

 Stage IIA

5 (6%)

 Stage IIB

8 (9%)

 Stage IIIA

3 (3%)

 Stage IIIB

21 (23%)

 Stage IV

26 (29%)

 Unknow

25 (28%)